Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-27

Clinical Trial Update: Intranasal CO2 for Allergic Rhinitis [NA]

View source ↗

Summary

A completed clinical trial tested intranasal carbon dioxide for allergic rhinitis, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal CO2 (carbon dioxide nasal spray)

Snippet

Sponsor: University of Chicago | Conditions: Allergic Rhinitis | NA | Status: COMPLETED | Results posted: 2014-01-27